Skizofrénia: ki dolgozik rajta

Intézményenként egy kártya. Válassz célpontot, és csak az azon dolgozó csoportok maradnak.

• Minden célpont
• NMDA 9
• BDNF 0
• GLP-1 1
• mTOR 0
• AKT 0
• PI3K 0
• TNF 0
• ERK 0
• IL-6 0
• NLRP3 0
• PPAR 0
• NRF2 0
• AMPK 0
• IL-17 0
• IL-23 1
• MAPK 0
• MAPT 0
• BACE1 0
• BCL-2 0
• C9orf72 0
• CD20 0
• COX-2 0
• DMD 0
• EGFR 0
• FOXP3 0
• FTO 0
• HMGB1 0
• IDO1 0
• IL-1 0
• JAK 0
• MMP-9 0
• PCSK9 0
• PDE4 0
• SCN2A 0
• SGLT2 0
• SIRT1 0
• STAT3 0
• TFEB 0
• TREM2 0
• VEGF 0

2591 intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Misinterpreting reality: Investigating the neural basis of hallucinatory percepts (MISHAPS)

  University College London· London, Egyesült Királyság· EU contribution 260 348 EUR· until 2029. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Interneuron subtype-specific control of hippocampal memory encoding and retrieval (INSPIRE)

  Universitaetsklinikum Freiburg· Freiburg, Németország· EU contribution 202 125 EUR· until 2029. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Continuous Estrogen Monitoring Patch (EstroPatch)

  Katholieke Universiteit Leuven· Leuven, Belgium· EU contribution 321 301 EUR· until 2030. máj.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Cannabis Neurobiology And Schizophrenia Risk in Youth: A Multi-Omics Translation (CANARY)

  Karolinska Institutet· Stockholm, Svédország· EU contribution 1 500 000 EUR· until 2031. dec.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Thalamic Nuclei Connectivity in the Psychosis Continuum: Parsing Clinical Heterogeneity and Individual Trajectories (THALAMIND)

  Universite de Geneve· Geneve, Svájc· EU contribution 469 989 EUR· until 2029. dec.· 2 countries

5 of 52 running projects, newest first. Listed amounts together: 125,4 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Leállították

  Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

  NCT05603104· Dr. Inge Winter· Frissítve: 2026. nov. 5.

  “The site in Israel stopped recruitment due to logistic reasons. Other sites are recruiting for 2023-506602-39-00, 2023-506605-19-00, 2023-506617-21-00.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  D-serine AudRem: R33 Phase

  NCT05046353· New York State Psychiatric Institute· Frissítve: 2026. nov. 2.

  “U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. NKI site is open for enrollment.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia

  NCT07084831· European Group for Research In Schizophrenia· Frissítve: 2026. okt. 30.

  “Ethical committee in Europe did not provide approval”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

  NCT04368039· Nicholas Breitborde· Frissítve: 2026. okt. 16.

  “Vendor unable to continue to provide oxygen concentrators”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Ketogenic Diet in People With Schizophrenia

  NCT05968638· University of Maryland, Baltimore· Frissítve: 2026. okt. 9.

  “Secretary of Health for the State of MD halted all inpatient research that was not federally funded”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia

  NCT03648268· Beth Israel Deaconess Medical Center· Frissítve: 2026. jún. 25.

  “Study ended due to end of project funding”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  OnTrackNY's Learning Healthcare System

  NCT04021719· New York State Psychiatric Institute· Frissítve: 2026. jún. 23.

  “U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning.

  NCT01979796· University of Catania· Frissítve: 2026. máj. 14.

  “We worked on a new dedicated protocolol GENESIS study”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Deep Brain Stimulation in Treatment Resistant Schizophrenia

  NCT02361554· Johns Hopkins University· Frissítve: 2026. máj. 14.

  “NIMH did not fund the 4th year of the UOI grant”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Intermittent Theta Burst Stimulation of the Precuneus

  NCT06142422· GCS Ramsay Santé pour l'Enseignement et la Recherche· Frissítve: 2026. máj. 4.

  “The sponsor decided to terminate the study early on April 21, 2026. No patients were enrolled in this study.”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

  NCT07288567· Bristol-Myers Squibb· Forrás

• Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia

  NCT07592169· University of California, San Diego· Forrás

• A Study to Evaluate the Effect of KarXT on Urological Safety

  NCT07221877· Bristol-Myers Squibb· Forrás

• Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3

  NCT07900893· Washington University School of Medicine· Forrás

• Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

  NCT07853807· Washington University School of Medicine· Forrás

• Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2

  NCT07875790· Washington University School of Medicine· Forrás

• A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  NCT07424404· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

  NCT05603104· Dr. Inge Winter· Forrás

• MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI

  NCT06138054· VA Office of Research and Development· Forrás

• Tau Biomarkers in Late-onset Psychosis (LOP)

  NCT06336382· Jeremy Koppel· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 8
• Organoids 5
• Mendelian Randomization Analysis 70
• CRISPR-Cas Systems 2
• Gene Expression Profiling 45
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 3
• Exome Sequencing 4
• Proteomics 30
• Metabolomics 24
• Mass Spectrometry 7
• Flow Cytometry 1
• Immunohistochemistry 8
• Positron-Emission Tomography 30
• Magnetic Resonance Imaging 385
• Machine Learning 81
• Deep Learning 17
• Cohort Studies 169
• Genome-Wide Association Study 174

• Estimating protein isoform abundances with [Formula: see text].

  Proc Natl Acad Sci U S A, 2026. szept.

• Optimizing Clozapine Use Through Therapeutic Drug Monitoring-Integrating Clinical and Laboratory Science Perspectives.

  Clin Lab Med, 2026. aug.

• Peptidomics and Beyond: Development of a Novel Platform Based on Capillary Electrophoresis-Mass Spectrometry for Metabolomics of Medium-Molecular-Weight Compounds.

  J Proteome Res, 2026. máj.

• [Breath metabolomic characteristics of schizophrenia and their potential for auxiliary diagnosis].

  Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2026. ápr.

• Metabolic Plasticity in Schizophrenia: Clinical Rehabilitation Meets LC-MS Metabolomics and Neurofeedback.

  Int J Mol Sci, 2025. dec.

• Prenatal vitamin D status and risk of psychotic experiences at age 18years-a longitudinal birth cohort.

  Schizophr Res, 2013. jún.

• Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species.

  J Psychiatr Res, 2010. jan.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.